ASCO Genitourinary Cancers Symposium
ASCO GU 2022: A Phase I/II Study of Nivo & Axitinib in Patients With Advanced RCC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Matthew Zibelman
By
ASCO Genitourinary Cancers Symposium
FEATURING
Matthew Zibelman
Login to view comments.
Click here to Login